Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Progression of Gastric Mucosal Dysplasia of the Postgastrectomy Stomach.

Marrero JM, Savalgi RS, McCormick C, Corbishley CM, Northfield TC.

Surg Technol Int. 2000 Oct;IX:333-337.

PMID:
12219315
3.

Ursodeoxycholic acid enhances fractional calcium absorption in primary biliary cirrhosis.

Verma A, Maxwell JD, Ang L, Davis T, Hodges S, Northfield TC, Zaidi M, Pazianas M.

Osteoporos Int. 2002 Aug;13(8):677-82.

PMID:
12181628
4.

Review article: faecal markers in the assessment of activity in inflammatory bowel disease.

Poullis A, Foster R, Northfield TC, Mendall MA.

Aliment Pharmacol Ther. 2002 Apr;16(4):675-81. Review.

5.

Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group.

Petroni ML, Jazrawi RP, Pazzi P, Lanzini A, Zuin M, Pigozzi MG, Fracchia M, Galatola G, Alvisi V, Heaton KW, Podda M, Northfield TC.

Aliment Pharmacol Ther. 2001 Jan;15(1):123-8.

6.

Progression of gastric mucosal dysplasia of the postgastrectomy stomach.

Marrero JM, Savalgi RS, McCormick C, Corbishley CM, Northfield TC.

Surg Technol Int. 2000;9:333-7.

PMID:
21136423
7.

Postprandial refilling and turnover: specific gallbladder motor function defects in patients with gallstone recurrence.

Pazzi P, Petroni ML, Prandini N, Adam JA, Gullini S, Northfield TC, Jazrawi RP.

Eur J Gastroenterol Hepatol. 2000 Jul;12(7):787-94.

PMID:
10929907
8.

Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group.

Petroni ML, Jazrawi RP, Pazzi P, Zuin M, Lanzini A, Fracchia M, Facchinetti D, Alvisi V, Ferraris R, Bland JM, Heaton KW, Podda M, Northfield TC.

Eur J Gastroenterol Hepatol. 2000 Jun;12(6):695-700.

PMID:
10912491
9.

Relationship between Helicobacter pylori, gastric parietal cell antibodies and heat shock proteins.

Asante MA, Mendall MA, Ballam L, Morris J, Northfield TC.

Eur J Gastroenterol Hepatol. 1999 Dec;11(12):1365-70.

PMID:
10654796
10.

Demonstration and partial characterisation of phospholipid methyltransferase activity in bile canalicular membrane from hamster liver.

Verma A, Ahmed HA, Davis T, Jazrawi RP, Northfield TC.

J Hepatol. 1999 Nov;31(5):852-9.

PMID:
10580582
11.

Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis.

Verma A, Jazrawi RP, Ahmed HA, Davis T, Bland JM, Benson M, Orchard RT, Theodossi A, Maxwell JD, Northfield TC.

Eur J Gastroenterol Hepatol. 1999 Oct;11(10):1069-76.

PMID:
10524634
12.

Prescribing habits in primary biliary cirrhosis: a national survey.

Verma A, Jazrawi RP, Ahmed HA, Northfield TC.

Eur J Gastroenterol Hepatol. 1999 Aug;11(8):817-20.

PMID:
10514110
13.

A randomized trial of endoscopy vs no endoscopy in the management of seronegative Helicobacter pylori dyspepsia.

Asante MA, Mendall M, Patel P, Ballam L, Northfield TC.

Eur J Gastroenterol Hepatol. 1998 Dec;10(12):983-9.

PMID:
9895042
14.

Determinants of prescribing costs for ulcer-healing drugs and upper gastrointestinal endoscopy in general practice.

Asante MA, Mendall MA, Bland JM, Northfield TC.

Eur J Gastroenterol Hepatol. 1998 Jul;10(7):589-93.

PMID:
9855084
15.

Variation in taste of topical lignocaine anaesthesia for gastroscopy.

Asante MA, Northfield TC.

Aliment Pharmacol Ther. 1998 Jul;12(7):685-6.

16.

Dissolution of gallbladder stones with methyl tert-butyl ether and stone recurrence: a European survey.

Hellstern A, Leuschner U, Benjaminov A, Ackermann H, Heine T, Festi D, Orsini M, Roda E, Northfield TC, Jazrawi R, Kurtz W, Schmeck-Lindenau HJ, Stumpf J, Eidsvoll BE, Aadland E, Lux G, Boehnke E, Wurbs D, Delhaye M, Cremer M, Sinn I, Höring E, v Gaisberg U, Neubrand M, Paul F, et al.

Dig Dis Sci. 1998 May;43(5):911-20. Erratum in: Dig Dis Sci 1998 Nov;43(11):2572.

PMID:
9590398
17.

Which Helicobacter pylori-positive dyspeptics are likely to respond symptomatically to empirical H. pylori eradication?

Asante MA, Mendall MA, Northfield TC.

Eur J Gastroenterol Hepatol. 1998 Mar;10(3):265-8.

PMID:
9585033
18.

The impact of direct access endoscopy, Helicobacter pylori near patient testing and acid suppressants on the management of dyspepsia in general practice.

Asante MA, Patel P, Mendall M, Jazrawi R, Northfield TC.

Int J Clin Pract. 1997 Nov-Dec;51(8):497-9.

PMID:
9536602
20.

Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease.

Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, Camm AJ, Northfield TC.

Heart. 1997 Sep;78(3):273-7.

21.

Epidemiology and association with extra-gastrointestinal diseases.

Mégraud F, Ponzetto A, Attili A, Figura N, Fox J, Gasbarrini A, Miglioli M, Mura I, Neri M, Northfield TC, Oderda G, Pretolani S.

Eur J Gastroenterol Hepatol. 1997 Jun;9(6):615. No abstract available.

PMID:
9222735
22.

Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy.

Lim AG, Wolfhagen FH, Verma A, van Buuren HR, Jazrawi RP, Levy JH, Northfield TC, Schalm SW.

Eur J Gastroenterol Hepatol. 1997 Feb;9(2):155-61.

PMID:
9058626
23.

Helicobacter pylori infection.

Goodwin CS, Mendall MM, Northfield TC.

Lancet. 1997 Jan 25;349(9047):265-9. Review. No abstract available.

PMID:
9014926
24.

Repeated bile acid therapy for the long-term management of cholesterol gallstones.

Petroni ML, Jazrawi RP, Lanzini A, Zuin M, Pazzi P, Fracchia M, Boga E, Facchinetti D, Alvisi V, Galatola G, Bland JM, Heaton KW, Podda M, Northfield TC.

J Hepatol. 1996 Nov;25(5):719-24.

PMID:
8938551
25.

Gastro-oesophageal reflux in patients with coronary artery disease: how common is it and does it matter?

Mehta AJ, de Caestecker JS, Camm AJ, Northfield TC.

Eur J Gastroenterol Hepatol. 1996 Oct;8(10):973-8.

PMID:
8930561
26.

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study.

Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC.

BMJ. 1996 Apr 27;312(7038):1061-5.

28.

HMG-CoA reductase inhibitors and bile lithogenicity: cholesterol supersaturation or nucleation defect?

Ahmed HA, Jazrawi RP, Northfield TC.

Eur J Gastroenterol Hepatol. 1996 Mar;8(3):195-6. No abstract available.

PMID:
8724015
29.

Risk assessment after acute upper gastrointestinal haemorrhage.

Rockall TA, Logan RF, Devlin HB, Northfield TC.

Gut. 1996 Mar;38(3):316-21.

30.

Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration.

Khulusi S, Badve S, Patel P, Lloyd R, Marrero JM, Finlayson C, Mendall MA, Northfield TC.

Gastroenterology. 1996 Feb;110(2):452-8.

PMID:
8566592
31.

Gastric DNA content in postgastrectomy patients. Relationship to mucosal dysplasia.

Marrero JM, de Caestecker JS, Corbishley CM, McCormick C, Northfield TC.

Cancer. 1996 Jan 1;77(1):19-24.

PMID:
8630929
32.

Intrahepatic biliary cholesterol and phospholipid transport in humans: effect of obesity and cholesterol cholelithiasis.

Ahmed HA, Jazrawi RP, Goggin PM, Dormandy J, Northfield TC.

J Lipid Res. 1995 Dec;36(12):2562-73.

33.

Prospective screening of dyspeptic patients by Helicobacter pylori serology.

Patel P, Khulusi S, Mendall MA, Lloyd R, Jazrawi R, Maxwell JD, Northfield TC.

Lancet. 1995 Nov 18;346(8986):1315-8.

PMID:
7475768
34.

Direct assessment of the mechanism for a raised serum bile acid level in chronic liver disease.

de Caestecker JS, Jazrawi RP, Nisbett JA, Joseph AE, Maxwell JD, Northfield TC.

Eur J Gastroenterol Hepatol. 1995 Oct;7(10):955-61.

PMID:
8590141
35.

Direct assessment of the mechanism of raised serum bile acid in chronic liver disease.

de Caestecker JS, Jazrawi RP, Northfield TC.

Eur J Gastroenterol Hepatol. 1995 Oct;7(10):1011. No abstract available.

PMID:
8590133
36.

Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects.

Khulusi S, Mendall MA, Patel P, Levy J, Badve S, Northfield TC.

Gut. 1995 Sep;37(3):319-24.

37.

The ursodeoxycholic acid story in primary biliary cirrhosis.

Lim AG, Jazrawi RP, Northfield TC.

Gut. 1995 Sep;37(3):301-4. No abstract available.

38.

Prospective, multicenter study on value of computerized tomography (CT) in gallstone disease in predicting response to bile acid therapy.

Petroni ML, Jazrawi RP, Grundy A, Lanzini A, Pigozzi MG, Biasio A, Heaton KW, Virjee J, Northfield TC.

Dig Dis Sci. 1995 Sep;40(9):1956-62.

PMID:
7555450
39.
40.

Postprandial gallbladder motor function: refilling and turnover of bile in health and in cholelithiasis.

Jazrawi RP, Pazzi P, Petroni ML, Prandini N, Paul C, Adam JA, Gullini S, Northfield TC.

Gastroenterology. 1995 Aug;109(2):582-91.

PMID:
7615209
41.

Expression of trefoil peptides pS2 and human spasmolytic polypeptide in gastric metaplasia at the margin of duodenal ulcers.

Khulusi S, Hanby AM, Marrero JM, Patel P, Mendall MA, Badve S, Poulsom R, Elia G, Wright NA, Northfield TC.

Gut. 1995 Aug;37(2):205-9.

43.

Transmission of Helicobacter pylori infection.

Mendall MA, Northfield TC.

Gut. 1995 Jul;37(1):1-3. Review. No abstract available.

44.

The effects of unsaturated fatty acids on Helicobacter pylori in vitro.

Khulusi S, Ahmed HA, Patel P, Mendall MA, Northfield TC.

J Med Microbiol. 1995 Apr;42(4):276-82.

PMID:
7707336
45.

Soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in primary biliary cirrhosis.

Lim AG, Jazrawi RP, Levy JH, Petroni ML, Douds AC, Maxwell JD, Northfield TC.

J Hepatol. 1995 Apr;22(4):416-22.

PMID:
7545197
46.

Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy.

Mendall MA, Jazrawi RP, Marrero JM, Molineaux N, Levi J, Maxwell JD, Northfield TC.

Gut. 1995 Mar;36(3):330-3.

47.

Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease.

Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levi J, Toosey T, Camm AJ, Northfield TC.

J Infect. 1995 Mar;30(2):121-8.

PMID:
7636277
48.

Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum.

Khulusi S, Mendall MA, Badve S, Patel P, Finlayson C, Northfield TC.

Gut. 1995 Feb;36(2):193-7. Erratum in: Gut 1995 Aug;37(2):300.

49.

Effects of acid suppression on microbial flora of upper gut.

Yeomans ND, Brimblecombe RW, Elder J, Heatley RV, Misiewicz JJ, Northfield TC, Pottage A.

Dig Dis Sci. 1995 Feb;40(2 Suppl):81S-95S. Review.

PMID:
7859586
50.

Sensitization to painful distention and abnormal sensory perception in the esophagus.

Mehta AJ, De Caestecker JS, Camm AJ, Northfield TC.

Gastroenterology. 1995 Feb;108(2):311-9.

PMID:
7835571

Supplemental Content

Loading ...
Support Center